Efficacy of durvalumab in patients with stage III NSCLC who experience pneumonitis (PACIFIC)
Name:
mdz259.002.pdf
Size:
107.8Kb
Format:
PDF
Description:
From UNPAYWALL. Conference abstract
Authors
Vansteenkiste, JFNaidoo, J
Faivre-Finn, Corinne
Ozguroglu, M
Villegas, A
Daniel, D
Murakami, S
Hui, R
Lee, KH
Cho, BC
Kubota, K
Taboada, M
Wadsworth, C
Dennis, PA
Antonia, SJ
Affiliation
Department of Respiratory Diseases, University Hospitals KU Leuven, Leuven, BelgiumIssue Date
2019
Metadata
Show full item recordCitation
Vansteenkiste JF, Naidoo J, Faivre-Finn C, Özgüroğlu M, Villegas A, Daniel D, et al. 1459PD Efficacy of durvalumab in patients with stage III NSCLC who experience pneumonitis (PACIFIC). Annals of Oncology. 2019;30(Supplement_5):592.Journal
Annals of OncologyDOI
10.1093/annonc/mdz259.002Additional Links
https://dx.doi.org/10.1093/annonc/mdz259.002Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdz259.002